GSK plc
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Ms. Emma Natasha Walmsley
- Full Time Employees
- 70,212
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Address
- 980 Great West Road Brentford United Kingdom TW8 9GS
- IPO Date
- Invalid Date
- CIK
- 0001131399
- Website
- www.gsk.com
- Business
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Company News
GSK's Respiratory Drug Nucala Meets Goal in COPD Study
GSK drug promotes ‘significant and clinically meaningful reduction' in asthma symptoms
GSK sees positive COPD trial results
GSK's asthma drug Nucala meets main goal in smoker's lungs trial
3 GLP-1 Stocks to Buy Now For Big Long-Term Gains
Why Is Glaxo (GSK) Up 10.3% Since Last Earnings Report?
GSK's RSV Vaccine Arexvy Gets EU Nod for Adults Aged 50-59 Years
GSK Stock Gains 18.5% Year to Date: Time to Buy, Sell or Hold?
GSK: European Union approves label expansion for RSV jab
GSK shares jump on win in Delaware court over ongoing Zantac battle
GSK shares higher after Delaware Zantac ruling
GSK's ADC Drug for Lung Cancer Gets FDA's Breakthrough Tag
GSK gets fast-track approval from FDA for Chinese lung cancer drug
Top 10 pharmaceutical companies in 2024: S&P Global's latest ratings and rankings
GSK's discount unwarranted, especially with latest Zantac win, says broker
GSK to seek dismissal of Florida case against heartburn drug Zantac
GSK wins favourable ruling in US Zantac litigation
CureVac Announces Financial Results for the Second Quarter and First Half of 2024 and Provides Business Update
GSK (GSK) is a Top-Ranked Momentum Stock: Should You Buy?
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields